EA009816B1 - Method for preparing calcium-containing biologically-active addition - Google Patents
Method for preparing calcium-containing biologically-active addition Download PDFInfo
- Publication number
- EA009816B1 EA009816B1 EA200601324A EA200601324A EA009816B1 EA 009816 B1 EA009816 B1 EA 009816B1 EA 200601324 A EA200601324 A EA 200601324A EA 200601324 A EA200601324 A EA 200601324A EA 009816 B1 EA009816 B1 EA 009816B1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- calcium
- mixture
- water
- containing biologically
- infrared radiation
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims abstract description 9
- 239000011575 calcium Substances 0.000 title claims abstract description 9
- 229910052791 calcium Inorganic materials 0.000 title claims abstract description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 19
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 230000005855 radiation Effects 0.000 claims abstract description 7
- 229910000019 calcium carbonate Inorganic materials 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 5
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims abstract description 4
- 239000001095 magnesium carbonate Substances 0.000 claims abstract description 4
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims abstract description 4
- 238000002360 preparation method Methods 0.000 claims description 6
- 239000000654 additive Substances 0.000 claims description 4
- 235000015165 citric acid Nutrition 0.000 description 5
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 3
- 239000001354 calcium citrate Substances 0.000 description 3
- 229910001424 calcium ion Inorganic materials 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 235000013337 tricalcium citrate Nutrition 0.000 description 3
- 206010006956 Calcium deficiency Diseases 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229940069978 calcium supplement Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000009134 cell regulation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000011167 hydrochloric acid Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000008611 intercellular interaction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/32—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with electric currents without heating effect
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/30—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
Description
Изобретение относится к пищевой промышленности и фармацевтическому производству биологически активных добавок (БАД), а именно кальцийсодержащих добавок, и может найти применение в лечебном питании и в медицине.The invention relates to the food industry and pharmaceutical production of biologically active additives (BAA), namely calcium supplements, and can find application in clinical nutrition and medicine.
Как известно, кальций является одним из основных элементов организма человека. Кальций играет важную роль в формировании костной ткани и сохранении ее нормальной структуры и функции. Наряду со специальными белками, ионы кальция обеспечивают твердость и эластичность костной ткани. Установлено, что ионы кальция принимают участие в возбуждении и сокращении мышечных клеток, регуляции проницаемости клеточных мембран, межклеточных взаимодействий, свертывания крови, секреции гормонов, медиаторов, ферментов, выполняют функцию преобразователя сигналов, поступающих в клетку, участвуют в процессах регуляции внутриклеточного обмена веществ, в том числе энергетического.Calcium is known to be one of the main elements of the human body. Calcium plays an important role in the formation of bone tissue and the preservation of its normal structure and function. Along with special proteins, calcium ions provide bone hardness and elasticity. It has been established that calcium ions are involved in the excitation and contraction of muscle cells, regulation of cell membrane permeability, intercellular interactions, blood coagulation, hormone secretion, mediators, enzymes, function as a signal transducer entering the cell, participate in the processes of regulation of intracellular metabolism, including energy.
Дефицит кальция проявляется в повышенной возбудимости нервной системы, аллергических реакциях, судорогах, остеопорозе, у детей - в проявлениях рахита, отставании в росте, частых простудных заболеваниях.Calcium deficiency is manifested in increased excitability of the nervous system, allergic reactions, convulsions, osteoporosis, in children - in the manifestations of rickets, growth retardation, frequent colds.
Все это послужило теоретическим фундаментом для разработки и внедрения в медицинскую практику препаратов кальция, созданных на основе его солей. В настоящее время в медицинской практике применяются такие соли кальция, как глицерофосфат, глюконат, карбонат, лактат, цитрат, хлорид, фосфат и многие другие.All this served as a theoretical foundation for the development and introduction of calcium preparations based on its salts into medical practice. At present, such calcium salts as glycerophosphate, gluconate, carbonate, lactate, citrate, chloride, phosphate and many others are used in medical practice.
Усвоению ионов кальция способствует витамин Ό, соляная и лимонные кислоты, лактоза, фосфор, магний.The absorption of calcium ions contributes to vitamin Ό, hydrochloric and citric acids, lactose, phosphorus, magnesium.
Известная кальцийсодержащая добавка - кальцийцитрат 4-водный, выпускаемая Уральским заводом химических реактивов (ТУ 6-09-09263-85, ч), представляет собой белый кристаллический порошок, полученный путем смешивания карбоната кальция СаСО3 с лимонной кислотой в пропорции 1:1. Лимонную кислоту растворяют в дистиллированной воде в концентрации 20-50 г на 1 л и при постоянном перемешивании добавляют эквивалентное количество СаСО3. Полученный раствор цитрата кальция высушивают до образования порошка белого цвета, который может быть спрессован в виде таблеток.Known calcium-containing additive - calcium citrate 4-water, manufactured by the Ural chemical reagent plant (TU 6-09-09263-85, h), is a white crystalline powder obtained by mixing calcium carbonate CaCO 3 with citric acid in a 1: 1 ratio. Citric acid is dissolved in distilled water at a concentration of 20-50 g per 1 l and, with constant stirring, an equivalent amount of CaCO 3 is added. The resulting calcium citrate solution is dried until a white powder is formed, which can be compressed into tablets.
Недостатком данного цитрата кальция является то, что он с трудом проглатывается, имеет горький вкус и плохо растворим в воде. Недостатком является также то, что он плохо усваивается организмом (не более 30%).The disadvantage of this calcium citrate is that it is difficult to swallow, has a bitter taste and is poorly soluble in water. The disadvantage is that it is poorly absorbed by the body (no more than 30%).
Целью настоящего изобретения является получение кальцийсодержащего продукта, хорошо усваиваемого организмом, обладающего приятным вкусом и легко потребляемого.The aim of the present invention is to obtain a calcium-containing product that is well absorbed by the body, has a pleasant taste and is easily consumed.
Указанная цель достигается тем, что получаемая предлагаемым способом кальцийсодержащая биологически активная добавка (БАД) представляет собой водную однородную мелкодисперсную суспензию, лишенную непрятного вкуса и запаха, и изготавливается из очищенного карбоната кальция с добавлением карбоната магния. А специальная обработка БАД, в процессе ее приготовления, магнитным полем и инфракрасным излучением повышает потребительские свойства и усваиваемость человеческим организмом.This goal is achieved by the fact that obtained by the proposed method calcium-containing biologically active additive (BAA) is an aqueous homogeneous fine suspension, devoid of unpleasant taste and smell, and is made of purified calcium carbonate with the addition of magnesium carbonate. A special treatment of dietary supplements, in the process of its preparation, with a magnetic field and infrared radiation increases consumer properties and digestibility of the human body.
Предлагаемый способ приготовления БАД заключается в следующем. Воду, предпочтительно очищенную кипяченую или дистиллированную, перемешивая, обрабатывают постоянным магнитным полем, затем в нее добавляют лимонную кислоту, химически чистые карбонат кальция и карбонат магния и в процессе перемешивания на смесь воздействуют инфракрасным излучением.The proposed method for the preparation of dietary supplements is as follows. Water, preferably purified boiled or distilled, is stirred, treated with a constant magnetic field, then citric acid, chemically pure calcium carbonate and magnesium carbonate are added to it and, during the mixing process, the mixture is exposed to infrared radiation.
Пример л дистиллированной воды при температуре 20-25°С, перемешивая, помещают на 10 мин в постоянное магнитное поле с напряженностью до 5,5 а/м (»400 эрстед). Затем в обработанную воду добавляют при постоянном перемешивании 30 г очищенных (марки Ч) СаСО3, 0,3 г МдСО3 и 30 г лимонной кислоты. В процессе приготовления на смесь воздействуют инфракрасным излучением с длиной волны от 2 до 40 мкм. Лучшие результаты достигаются при последовательном воздействии нескольких источников излучения. Например, воздействуют четырьмя группами излучателей продолжительностью от 25 до 45 мин каждая. Полученная смесь выдерживается при температуре от 10 до 25°С в течение 24 ч.An example of distilled water at a temperature of 20–25 ° C, while stirring, is placed in a constant magnetic field with a strength of up to 5.5 a / m for 10 min (≈400 oersted). Then, 30 g of purified (brand H) CaCO 3 , 0.3 g of MdSO 3 and 30 g of citric acid are added to the treated water with constant stirring. In the process of preparation, the mixture is exposed to infrared radiation with a wavelength of 2 to 40 microns. The best results are achieved with the sequential exposure of several radiation sources. For example, they are affected by four groups of emitters with a duration of 25 to 45 minutes each. The resulting mixture is aged at a temperature of from 10 to 25 ° C for 24 hours.
Полученная смесь представляет собой водную однородную мелкодисперсную суспензию, лишенную неприятного вкуса и запаха и с хорошими потребительскими свойствами.The resulting mixture is an aqueous homogeneous fine suspension, devoid of unpleasant taste and odor and with good consumer properties.
Кроме того биологически активная добавка быстро и почти полностью (до 90%) усваивается организмом и в короткие сроки восполняет дефицит кальция, нормализует остеосинтез, участвует в синтезе с АТФ, нормализует проницаемость мембран и стенок сосудов, повышает иммунитет, восстанавливает холестериновый и минеральный обмен.In addition, the dietary supplement is quickly and almost completely (up to 90%) absorbed by the body and quickly compensates for calcium deficiency, normalizes osteosynthesis, participates in the synthesis of ATP, normalizes the permeability of the membranes and vascular walls, boosts immunity, restores cholesterol and mineral metabolism.
Claims (2)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EA200601324A EA009816B1 (en) | 2006-05-23 | 2006-05-23 | Method for preparing calcium-containing biologically-active addition |
| PCT/KZ2007/000007 WO2007136238A1 (en) | 2006-05-23 | 2007-05-16 | Method for producing a biologically active additive named 'active calcium' |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EA200601324A EA009816B1 (en) | 2006-05-23 | 2006-05-23 | Method for preparing calcium-containing biologically-active addition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200601324A1 EA200601324A1 (en) | 2007-12-28 |
| EA009816B1 true EA009816B1 (en) | 2008-04-28 |
Family
ID=38723524
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200601324A EA009816B1 (en) | 2006-05-23 | 2006-05-23 | Method for preparing calcium-containing biologically-active addition |
Country Status (2)
| Country | Link |
|---|---|
| EA (1) | EA009816B1 (en) |
| WO (1) | WO2007136238A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA020345B1 (en) * | 2011-02-14 | 2014-10-30 | Абдухамит Абдувалиевич Фаттахов | Method for preparing biologically-active additive |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2703719C1 (en) * | 2018-04-18 | 2019-10-22 | Федеральное государственное бюджетное научное учреждение "Поволжский научно-исследовательский институт производства и переработки мясомолочной продукции" (ГНУ НИИММП) | Method of producing calcium citrate |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2030871C1 (en) * | 1992-06-16 | 1995-03-20 | Акционерное общество закрытого типа "Деко" | Bakery and macaroni products production method |
| JPH08198803A (en) * | 1995-01-27 | 1996-08-06 | Fuji Chem Ind Co Ltd | Composition of amorphous citric acid, organic acid, calcium and magnesium and its production |
| RU2083140C1 (en) * | 1994-09-20 | 1997-07-10 | Пальмов Федор Владимирович | Method for treating thin layer of liquid by radiation |
| EA001375B1 (en) * | 1996-02-20 | 2001-02-26 | Смитклайн Бичем Пи-Эл-Си | Liquid oral composition comprising a calcium compound and an acidulant |
| RU2261024C2 (en) * | 1999-09-24 | 2005-09-27 | Сосьете Де Продюи Нестле С.А. | Liquid food product enriched with calcium and magnesium, and method for producing the same (versions) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2155081C1 (en) * | 1999-11-25 | 2000-08-27 | Солодилов Александр Иванович | Method and device for treating substance in magnetic field |
| RU2270586C2 (en) * | 2004-04-08 | 2006-02-27 | Дальневосточная Государственная Академия Экономики И Управления (Двгаэу) | Food calcium-containing supplement and functional foodstuff containing the same |
-
2006
- 2006-05-23 EA EA200601324A patent/EA009816B1/en not_active IP Right Cessation
-
2007
- 2007-05-16 WO PCT/KZ2007/000007 patent/WO2007136238A1/en active Application Filing
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2030871C1 (en) * | 1992-06-16 | 1995-03-20 | Акционерное общество закрытого типа "Деко" | Bakery and macaroni products production method |
| RU2083140C1 (en) * | 1994-09-20 | 1997-07-10 | Пальмов Федор Владимирович | Method for treating thin layer of liquid by radiation |
| JPH08198803A (en) * | 1995-01-27 | 1996-08-06 | Fuji Chem Ind Co Ltd | Composition of amorphous citric acid, organic acid, calcium and magnesium and its production |
| EA001375B1 (en) * | 1996-02-20 | 2001-02-26 | Смитклайн Бичем Пи-Эл-Си | Liquid oral composition comprising a calcium compound and an acidulant |
| RU2261024C2 (en) * | 1999-09-24 | 2005-09-27 | Сосьете Де Продюи Нестле С.А. | Liquid food product enriched with calcium and magnesium, and method for producing the same (versions) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA020345B1 (en) * | 2011-02-14 | 2014-10-30 | Абдухамит Абдувалиевич Фаттахов | Method for preparing biologically-active additive |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007136238A1 (en) | 2007-11-29 |
| EA200601324A1 (en) | 2007-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2533641C (en) | Lactoperoxidase as an osteogenesis promoter | |
| WO2006112012A1 (en) | Nutrient composition | |
| IL127148A (en) | Creatine pyruvates, method for their production and physiologically compatible compositions containing them | |
| JP2002540807A (en) | Dietary supplement derived from fermented milk for the prevention of osteoporosis | |
| CN101842385B (en) | Food material for inhibiting formation of osteoclast | |
| CN101861332B (en) | Food material for promoting the differentiation of osteoblast and inhibiting the differentiation of osteoclast | |
| JP2005119983A (en) | Nutritive composition | |
| EP1371289A1 (en) | Choline-silicic acid complex | |
| EA009816B1 (en) | Method for preparing calcium-containing biologically-active addition | |
| US8647619B2 (en) | Osteogenesis promoter | |
| JP2004238320A (en) | Bone absorption inhibitor | |
| JP3742523B2 (en) | Polymeric calcium phosphopeptide complex | |
| US6203827B1 (en) | Composition containing readily absorbable calcium and process for producing the same | |
| RU2412604C1 (en) | Dairy whey enriched with lactates (versions) | |
| JP2660906B2 (en) | Method for producing sea urchin-derived calcium and composition containing easily absorbable calcium obtained by this method | |
| JP3131385B2 (en) | Composition containing easily absorbable calcium and method for producing the same | |
| Tiwari et al. | Egg Shell: An Essential Waste Product to Improve Dietary Calcium Uptake | |
| JPH05161480A (en) | Amino acid-containing calcium composition and calcium beverage containing the same composition | |
| KR20100105561A (en) | Food material for inhibiting bone resorption | |
| KR20050013912A (en) | Calcium ion drink that intake uses posible hi-condensed calcium aqueous solution manufacture method and this | |
| CN112370430A (en) | Calcium and vitamin K2 tablet and preparation method thereof | |
| JPH04234960A (en) | Calcium enriched food and production thereof | |
| KR102428137B1 (en) | Composition for supplementing calcium | |
| CN115024364A (en) | Formula goat milk powder for promoting growth and skeletal development of children and preparation method thereof | |
| RU2311803C1 (en) | Method for preparing mineral complex |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY MD TJ TM |
|
| PC4A | Registration of transfer of a eurasian patent by assignment | ||
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): KZ KG RU |